EP2350641
A COMBINATION OF A TNF ALPHA INHIBITOR, AN IAP INHIBITOR AND A TRAIL RECEPTOR AGONIST FOR USE IN TREATING CANCER
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
5.8.2009EP published:
24.9.2014EP application number:
09814951.1
EPO information:
European Patent Register
Max expiry date:
4.8.2029
Title:
A COMBINATION OF A TNF ALPHA INHIBITOR, AN IAP INHIBITOR AND A TRAIL RECEPTOR AGONIST FOR USE IN TREATING CANCER
Timeline
Today
5.8.2009EP application
24.9.2014EP Publication
Owner
Name:
Amgen Inc.Address:
One Amgen Center Drive M/S 28-2-C, 91320-1799, Thousand Oaks, CA, US
Name:
Tetralogic Pharmaceuticals CorporationAddress:
343 Phoenixville Pike, 19355, Malvern, PA, US
Inventor
Name:
HOLLAND, Pamela, M.Address:
Thousand Oaks, CA, US
Name:
PIASECKI, Julia, C.Address:
Thousand Oaks, CA, US
Name:
BENETATOS, Christopher, A.Address:
Malvern, PA, US
Name:
CHUNDURU, Srinivas, K.Address:
Malvern, PA, US
Name:
MCKINLAY, Mark, A.Address:
Malvern, PA, US
Priority
Number:
99088 PDate:
22.9.2008Country:
US
Classification
Categories:
A61K 38/17, A61K 31/52, A61K 39/395, A61P 35/00, A61K 45/06